Activating brown adipose tissue through exercise (ACTIBATE) in young adults: Rationale, design and methodology

• Published in: Contemporary clinical trials 2015-11, Vol.45 (Pt B), p.416-425
• Main Authors: Sanchez-Delgado, Guillermo, Martinez-Tellez, Borja, Olza, Josune, Aguilera, Concepcion M, Labayen, Idoia, Ortega, Francisco B, Chillon, Palma, Fernandez-Reguera, Carlos, Alcantara, Juan M.A, Martinez-Avila, Wendy D, Muñoz-Hernandez, Victoria, Acosta, Francisco M, Prados-Ruiz, Juan, Amaro-Gahete, Francisco J, Hidalgo-Garcia, Laura, Rodriguez, Lorena, Ruiz, Yasmeen Abdel-Karim, Ramirez-Navarro, Angel, Muros-de Fuentes, Maria A, García-Rivero, Yolanda, Sanchez-Sanchez, Rocio, de Dios Beas Jimenez, Juan, de Teresa, Carlos, Navarrete, Socorro, Lozano, Rosa, Brea-Gomez, Esther, Rubio-Lopez, Jose, Ruiz, Maria R, Cano-Nieto, Amalia, Llamas-Elvira, Jose M, Jimenez Rios, Jose A, Gil, Angel, Ruiz, Jonatan R
• Format: Article
• Language: English
• Subjects: Adipose Tissue, Brown - metabolism; Adolescent; Adult; Body Temperature Regulation; Brown adipose tissue; Cardiovascular; Energy Metabolism; Exercise - physiology; Female; Heart Rate; Hematology, Oncology and Palliative Medicine; Humans; Male; Multimodal Imaging; Obesity; Positron-Emission Tomography; Thermogenesis; Tomography, X-Ray Computed; Type 2 diabetes; Young Adult
• ISSN: 1551-7144; 1559-2030
• DOI: 10.1016/j.cct.2015.11.004

Abstract Aims The energy expenditure capacity of brown adipose tissue (BAT) makes it an attractive target as a therapy against obesity and type 2 diabetes. BAT activators namely catecholamines, natriuretic peptides and certain myokines, are secreted in response to exercise. ACTIBATE will determine the effect of exercise on BAT activity and mass measured by positron emission tomography/computed tomography (PET/CT, primary outcome) in young adults. ACTIBATE will also investigate the physiological consequences of activating BAT (secondary outcomes). Methods ACTIBATE will recruit 150 sedentary, healthy, young adults (50% women) aged 18–25 years. Eligible participants will be randomly assigned to a non-exercise group (n ≈ 50) or one of two exercise groups (n = 50 each). Participants in the exercise groups will perform aerobic and strength training 3–4 days/week at a heart rate equivalent to 60% of heart rate reserve (HRres), and at 50% of 1 repetition maximum (RM) for the moderate-intensity group, and at 80% of HRres and 70% RM for the vigorous-intensity group. Laboratory measures completed at baseline and 6 months include BAT activity and mass, resting energy expenditure, meal and cold-induced thermogenesis, body temperature regulation and shivering threshold, body composition and cardiovascular disease risk factors. We will also obtain biopsies from abdominal subcutaneous white adipose tissue and skeletal muscle to analyse the expression of genes encoding proteins involved in the thermogenic machinery. Discussion Findings from ACTIBATE will have significant implications for our understanding of exercise and its protective effects against the development of type 2 diabetes, obesity and related metabolic diseases. ClinicalTrials.gov ID: NCT02365129